Product Code: PM1130
The global arrhythmia market size is expected to reach USD 11.25 billion by 2030 according to a new study by Polaris Market Research. The report "Arrhythmia Market Share, Size, Trends, Industry Analysis Report, By Type (Supraventricular Tachycardias, Ventricular Arrhythmias, Bradyarrhythmias); By Site of Origin Atrial; By Test Equipment; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The introduction of technologically enhanced and innovative devices by the major players is driving the industry's growth. The industry's growth is likely to be aided by the development of technologically improved monitoring devices. Further, in July 2021, in the US, Abbott revealed Jot Dx, a new insertable cardiac monitor (ICM) designed to improve precise identification of difficult-to-detect irregular heart rhythms and reduce data burden. This technology allows for remote detection of cardiac arrhythmia and improves the accuracy of patient diagnosis.
Also, in March 2022, the ZOLL Arrhythmia Management System (AMS) from ZOLL Medical is a device that combines biometrics data with ECG data collected by typical mobile cardiac telemetry (MCT) devices. Over 60% of patients had their treatment plans changed once biometric data was added, including changes to lifestyle, drugs, and follow-up plans. Thus, these technologically advanced devices are boosting industry growth.
Based on the type, the tachycardia segment accounted for the leading share in the market. In the next years, the use of technologically enhanced solutions for disease monitoring is likely to boost demand for the tachycardia category. In 2021, atrial tachycardia accounted for the majority of the market and was predicted to continue to expand shortly.
It's a type of supraventricular tachycardia that needs to be treated aggressively for the best results. Cardiac-based devices serve an important role in improving illness detection and therapy. As a result of the rising risk of tachycardia, the cardiac market is expected to develop significantly shortly. Also, as per the CDC, around 40 Mn individuals in the U.S. still smoke, and 2.6 Mn school kids, including e-cigarette users. Every day, nearly 1,600 American teenagers under the age of 18 light up their 1st cigarette. Approximately 0.5 Mn people in the U.S. die prematurely each year. Another 16 million people suffer from a serious ailment as a result of smoking.
Market players such as Koninklijke Philips N.V., AliveCor, Biotronik, Biotricity, GE Healthcare, iRhythm Technologies, Medtronic plc., Nihon Kohden Corporation, St. Jude Medical (Abbott Laboratories), Spacelabs Healthcare (OSI Systems, Inc.), Applied Cardiac Systems, and Welch Allyn (Hillrom Services, Inc.) are some key players operating in the global market. In November 2021, Philips agreed to buy Cardiologs. This acquisition expands the company's cardiac monitoring and diagnostics product range, providing revenue growth potential in the industry.
Polaris Market Research has segmented the arrhythmia market report based on test equipment, site of origin atrial, type, and region:
Arrhythmia, Test Equipment Outlook (Revenue - USD Billion, 2018 - 2030)
Electrocardiogram (ECG)
Holter monitor
Arrhythmia, Site of Origin Atrial Outlook (Revenue - USD Billion, 2018 - 2030)
Sinus bradycardia
Premature atrial contractions (PACs)
Wandering atrial pacemaker
Atrial tachycardia
Multifocal atrial tachycardia
Supraventricular tachycardia (SVT)
Atrial flutter
Atrial fibrillation (Afib)
Arrhythmia, Type Outlook (Revenue - USD Billion, 2018 - 2030)
Supraventricular tachycardias
Ventricular
Bradyarrhythmias
Arrhythmia, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Russia
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Arrhythmia Market Insights
- 4.1. Arrhythmia - Industry Snapshot
- 4.2. Arrhythmia Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Change in lifestyle habits
- 4.2.1.2. Growing prevalence of cardiovascular diseases
- 4.2.2. Restraints and Challenges
- 4.2.2.1. HIgh cost of treatment
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Arrhythmia Market Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Arrhythmia Market, by Site of Origin Atrial
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 5.3. Sinus Bradycardia
- 5.3.1. Global Arrhythmia Market, by Sinus Bradycardia, by Region, 2018 - 2030 (USD Billion)
- 5.4. Premature Atrial Contractions (PACS)
- 5.4.1. Global Arrhythmia Market, by Premature Atrial Contractions (PACS), by Region, 2018 - 2030 (USD Billion)
- 5.5. Wandering Atrial Pacemaker
- 5.5.1. Global Arrhythmia Market, by Wandering Atrial Pacemaker, by Region, 2018 - 2030 (USD Billion)
- 5.6. Atrial Tachycardia
- 5.6.1. Global Arrhythmia Market, by Atrial Tachycardia, by Region, 2018 - 2030 (USD Billion)
- 5.7. Multifocal Atrial Tachycardia
- 5.7.1. Global Arrhythmia Market, by Multifocal Atrial Tachycardia, by Region, 2018 - 2030 (USD Billion)
- 5.8. Supraventricular Tachycardia (SVT)
- 5.8.1. Global Arrhythmia Market, by Supraventricular Tachycardia (SVT), by Region, 2018 - 2030 (USD Billion)
- 5.9. Atrial Flutter
- 5.9.1. Global Arrhythmia Market, by Atrial Flutter, by Region, 2018 - 2030 (USD Billion)
- 5.10. Atrial Fibrillation (Afib)
- 5.10.1. Global Arrhythmia Market, by Atrial Fibrillation (Afib), by Region, 2018 - 2030 (USD Billion)
6. Global Arrhythmia Market, by Test Equipment
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 6.3. Electrocardiogram (ECG)
- 6.3.1. Global Arrhythmia Market, by Electrocardiogram (ECG), by Region, 2018 - 2030 (USD Billion)
- 6.4. Holter Monitor
- 6.4.1. Global Arrhythmia Market, by Holter Monitor, by Region, 2018 - 2030 (USD Billion)
7. Global Arrhythmia Market, by Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 7.3. Supraventricular Tachycardias
- 7.3.1. Global Arrhythmia Market, by Supraventricular Tachycardias, by Region, 2018 - 2030 (USD Billion)
- 7.4. Ventricular Arrhythmias
- 7.4.1. Global Arrhythmia Market, by Ventricular Arrhythmias, by Region, 2018 - 2030 (USD Billion)
- 7.5. Bradyarrhythmias
- 7.5.1. Global Arrhythmia Market, by Bradyarrhythmias, by Region, 2018 - 2030 (USD Billion)
8. Global Arrhythmia Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Arrhythmia Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 8.3. Arrhythmia Market - North America
- 8.3.1. North America: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.3.2. North America: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.3.3. North America: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.3.4. Arrhythmia Market - U.S.
- 8.3.4.1. U.S.: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.3.4.2. U.S.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.3.4.3. U.S.: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.3.5. Arrhythmia Market - Canada
- 8.3.5.1. Canada: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.3.5.2. Canada.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.3.5.3. Canada: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.4. Arrhythmia Market - Europe
- 8.4.1. Europe: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.4.2. Europe.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.3. Europe: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.4.4. Arrhythmia Market - UK
- 8.4.4.1. UK: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.4.4.2. UK.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.4.3. UK: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.4.5. Arrhythmia Market - France
- 8.4.5.1. France: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.4.5.2. France.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.5.3. France: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.4.6. Arrhythmia Market - Germany
- 8.4.6.1. Germany: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.4.6.2. Germany.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.6.3. Germany: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.4.7. Arrhythmia Market - Italy
- 8.4.7.1. Italy: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.4.7.2. Italy.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.7.3. Italy: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.4.8. Arrhythmia Market - Spain
- 8.4.8.1. Spain: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.4.8.2. Spain.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.8.3. Spain: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.4.9. Arrhythmia Market - Netherlands
- 8.4.9.1. Netherlands: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.4.9.2. Netherlands.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.9.3. Netherlands: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.4.10. Arrhythmia Market - Russia
- 8.4.10.1. Russia: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.4.10.2. Russia.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.4.10.3. Russia: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.5. Arrhythmia Market - Asia Pacific
- 8.5.1. Asia Pacific: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.5.2. Asia Pacific.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.3. Asia Pacific: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.5.4. Arrhythmia Market - China
- 8.5.4.1. China: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.5.4.2. China.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.4.3. China: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.5.5. Arrhythmia Market - India
- 8.5.5.1. India: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.5.5.2. India.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.5.3. India: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.5.6. Arrhythmia Market - Malaysia
- 8.5.6.1. Malaysia: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.5.6.2. Malaysia.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.6.3. Malaysia: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.5.7. Arrhythmia Market - Japan
- 8.5.7.1. Japan: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.5.7.2. Japan.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.7.3. Japan: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.5.8. Arrhythmia Market - Indonesia
- 8.5.8.1. Indonesia: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.5.8.2. Indonesia.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.8.3. Indonesia: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.5.9. Arrhythmia Market - South Korea
- 8.5.9.1. South Korea: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.5.9.2. South Korea.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.5.9.3. South Korea: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.6. Arrhythmia Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.6.2. Middle East & Africa.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.6.3. Middle East & Africa: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.6.4. Arrhythmia Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.6.4.3. Saudi Arabia: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.6.5. Arrhythmia Market - UAE
- 8.6.5.1. UAE: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.6.5.2. UAE.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.6.5.3. UAE: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.6.6. Arrhythmia Market - Israel
- 8.6.6.1. Israel: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.6.6.2. Israel.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.6.6.3. Israel: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.6.7. Arrhythmia Market - South Africa
- 8.6.7.1. South Africa: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.6.7.2. South Africa.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.6.7.3. South Africa: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.7. Arrhythmia Market - Latin America
- 8.7.1. Latin America: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.7.2. Latin America.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.7.3. Latin America: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.7.4. Arrhythmia Market - Mexico
- 8.7.4.1. Mexico: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.7.4.2. Mexico.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.7.4.3. Mexico: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.7.5. Arrhythmia Market - Brazil
- 8.7.5.1. Brazil: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.7.5.2. Brazil.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.7.5.3. Brazil: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
- 8.7.6. Arrhythmia Market - Argentina
- 8.7.6.1. Argentina: Arrhythmia Market, by Site of Origin Atrial, 2018 - 2030 (USD Billion)
- 8.7.6.2. Argentina.: Arrhythmia Market, by Type, 2018 - 2030 (USD Billion)
- 8.7.6.3. Argentina: Arrhythmia Market, by Test Equipment, 2018 - 2030 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Applied Cardiac Systems
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. AliveCor
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Biotronik
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Biotricity
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. GE Healthcare
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. iRhythm Technologies
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Koninklijke Philips N.V
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Medtronic plc
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Nihon Kohden Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. St. Jude Medical (Abbott Laboratories)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Spacelabs Healthcare (OSI Systems, Inc.)
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Welch Allyn (Hillrom Services, Inc.)
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development